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Granulomatous Diseases 
Mimicking Sarcoidosis
Angel Robles-Marhuenda
Abstract
Granulomatous diseases are not infrequent in daily clinical practice. 
Granulomas are the expression of a sufficiently (partial) functioning immune 
system. Many diseases, with different etiologies (infection, autoimmunity, 
inflammatory, foreign bodies, malignancy, metabolites, chemicals, etc.) can 
cause granulomatous manifestations. The differential diagnostic process of a 
granulomatous disease should always be made in an interdisciplinary cooperation. 
Diagnostic procedures should be oriented to the clinical symptoms suggestive 
microbiological studies, and radiography but the diagnosis of a granulomatous 
disease should always be confirmed by histopathology when possible, sampling 
for histology or cytology. From a pathogenic point of view, they are divided into 
noninfectious and infectious granulomas. In the case of proven granulomatous 
inflammation, an infectious etiology should first be excluded (including 
mycobacteria, parasites, and fungi). From a clinical point of view, it is useful to 
separate granulomatosis into localized and disseminated forms, although this 
distinction can be sometimes artificial. Three types of localized granulomatous 
lesions can be distinguished: infectious granulomas, palisaded granulomas 
(granuloma annulare, necrobiosis lipoidica, and rheumatoid nodules), and foreign 
body granulomas. Disseminated granulomas can be divided into infectious, in 
particular tuberculosis, and noninfectious forms (autoimmune, neoplasia, etc.).
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1. Introduction
Granulomatous diseases are not uncommon in daily clinical practice. Different 
etiologies (infection, autoimmunity, inflammation, foreign bodies, malignancy, 
metabolites, chemicals, etc.) can cause granulomatous lesions.
The differential diagnostic process for a granulomatous disease should always 
be made in light of interdisciplinary cooperation as it requires close collaboration 
between specialists including radiologists, internists, and pathologists.
Diagnostic procedures should be oriented to the clinical symptoms and should 
include blood analyses (liver and renal function control check, etc.), suggestive 
microbiological studies, and radiography (especially computed tomography or 
magnetic resonance imaging or positron emission tomography); the diagnosis 
of a granulomatous disease should always be confirmed by histopathology when 
possible, sampling for histology or cytology.
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From a pathologic point of view, the lesions are divided into noninfectious and 
infectious granulomas. In the case of proven granulomatous inflammation, an 
infectious etiology (including mycobacteria, parasites, and fungi) should first be 
excluded.
From a clinical point of view, it is useful to separate granulomatosis into 
localized and disseminated forms, although this distinction can be sometimes 
artificial. Three types of localized granulomatous lesions can be distinguished: 
infectious granulomas, which are generally associated with localized infections, 
palisaded granulomas (granuloma annulare, necrobiosis lipoidica, and rheumatoid 
nodules), and foreign body granulomas. Disseminated granulomas can be divided 
into infectious (in particular tuberculosis) and noninfectious forms (autoimmune, 
neoplasia, etc.). These entities are discussed herein.
Granulomatous disorders are a heterogeneous group of diseases, the pathophysi-
ological mechanism of which is still poorly understood. These are granulomatous 
inflammatory reactions to a wide variety of stimuli, including infections, systemic 
inflammations, neoplasia, metabolic disorders, and chemicals.
A granuloma is a specific form of inflammation involving mostly dendritic cells, 
T lymphocytes, and macrophages, which are the dominant cell type. Both innate and 
adaptive immunity are involved in this inflammatory process. From a clinical point 
of view, it is useful to separate granulomatosis into localized and disseminated forms, 
although this distinction may sometimes be artificial, because they often coexist. 
These are most frequently seen as pulmonary, hepatobiliary-splenic, gastrointestinal, 
renal, cerebral, and bone granulomas. From a pathogenic point of view, they are 
divided into noninfectious and infectious granulomas. Treatment is specific for 
each type.
2. Cutaneous localizad granulomatosis
The typical macroscopic skin lesion of cutaneous granulomatosis is characterized 
by an infiltrated painless rounded papule, which is well limited and reddish-pink 
and takes a yellowish color on diascopy, called apple jelly. Its surface is smooth or 
slightly squamous as there is generally no epidermal involvement [1].Three types 
of localized skin granulomatous lesions can be distinguished, namely, palisaded 
granulomas (like granuloma annulare, necrobiosis lipoidica, or rheumatoid 
nodules), infectious granulomas (which are generally associated with localized 
infections), and foreign body granulomas [1, 2].
2.1 Palisadic granulomas
This term corresponds to a histological description of a nodular inflammatory 
granulomatous lesion characterized by a central zone of altered connective tissue, 
surrounded by histiocytes dispersed in a palisaded form. The anomalies observed at 
the center of the granulomas generally make it possible to distinguish the different 
forms: mucin deposits in granuloma annulare, necrosis in necrobiosis lipoidica, and 
massive necrosis with fibrin deposits in rheumatoid nodules.
2.1.1 Granuloma annulare
This is the most commonly occurring form of cutaneous granulomas; two 
thirds of patients are under 30 years of age, with a male to female ratio of 2:1. Skin 
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involvement predominates in the extremities and rarely involves the face. The 
localized form is the more common (75% of the cases) than disseminated disease. 
Disseminated granuloma annulare has also been described, sometimes isolated and 
sometimes reported to be in association with several conditions (i.e., paraneoplastic 
forms associated with solid organ tumors or lymphoma). In these patients, the 
skin picture is often atypical [1]. The dermatological expression is in the form 
of erythematous plaques, grouped in rings with centrifugal progression. These 
plaques are themselves made up of small, firm, and well-defined papules. These 
lesions are asymptomatic and generally located on the back of the hands and feet, 
wrists, ankles, and dorsolateral faces of the fingers. In the disseminated form, it is 
arranged symmetrically, mainly on the trunk and the extremities. The diagnosis 
is clinical, the cutaneous biopsy being useful in doubtful cases. Sometimes the 
biopsy itself leads to a regression of the lesion. The evolution of these skin lesions 
is unpredictable but generally benign. Typically, the skin lesions disappear 
spontaneously within a few months to 2–3 years. Treatment is usually indicated 
when the lesions are very generalized.
2.1.2 Necrobiosis lipoidica
Necrobiosis lipoidica is an idiopathic chronic granulomatosis, which usually 
occurs in young or middle-aged adults, with a male to female ratio of 1:3. It is associ-
ated with diabetes mellitus, although its development is not related to poor glycemic 
control.
Necrobiosis refers to a histological inflammation triggered by cell death, and 
lipoidica refers to the clinically yellowish appearance of the lesions due to lipid 
deposits secondary to collagen degeneration. The lesions present as bilateral 
painless papules or nodules, which widen progressively and converge into well-
defined oval plaques with a raised erythematous border surrounding the central 
area, which is initially reddish and later becomes yellowish, smooth, and atrophic 
with telangiectasias and scarring. Over time, the plaque becomes indurated and 
adherent to the underlying osteoperiosteal planes, with a remaining active border. 
Isolated cases of squamous cell carcinomas have been reported in patients with large 
lesions.
2.1.3 Rheumatoid nodules
Rheumatoid nodules are the most frequent extra-articular manifestations of 
rheumatoid arthritis (RA). At least 20% of adult patients with RA have rheumatoid 
nodules. Patients with rheumatoid nodules are more often rheumatoid factor and 
anti-cyclic citrullinated peptide positive. Their presence in newly diagnosed patients 
can be considered as a clinical predictor of severe seropositive and erosive arthritis 
associated with extra-articular involvement, including rheumatoid vasculitis. They 
consist of deep dermo-hypodermic nodules of variable size (2 mm to 5 cm) adher-
ent to the periosteum. Generally painless, these nodules can cause discomfort or 
pain when they ulcerate. The nodules tend to develop in outbreaks during the active 
phases of the disease and form subcutaneously, in the bursas and along the tendi-
nous sheaths. Although they have been described in almost all regions and can occur 
in the viscera (lung, liver), these nodules are typically located at pressure points, 
such as on the extensor surface of the arm, the Achilles tendon, the ischial area, 
and on the flexor surfaces of the fingers. These lesions may develop gradually or 
abruptly and are usually associated with some symptoms of inflammation. A biopsy 
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of the nodule may be necessary if the diagnosis is uncertain. Over time, rheumatoid 
nodules often disappear or regress, evolving sometimes, independent of treatment. 
Rheumatoid nodules appearing without clinical or biological rheumatic symptoms 
are most often deep granuloma annulare or pseudorheumatoid nodules, particularly 
in children and in the cephalic region [1, 2].
2.1.4  Lupus miliaris disseminatus faciei (acne agminata; necrotizing 
granulomatous rosacea)
Lupus miliaris disseminatus faciei is now believed to be a peculiar variant of 
rosacea. It presents with multiple reddish papules and nodules of the scalp and 
face, principally in young adults, and is centered on hair follicles, without pus 
formation. It usually persists for 2–3 years and then regresses, leaving residual 
scars [2].
2.2 Foreign body granulomas
Foreign body granulomas consist of an excessive cutaneous inflammatory 
response to any material in the dermis or subcutis (endogenous or exogenous). 
The clinical presentation and evolution depends on several factors: tissue response 
to the foreign body, anatomical site, penetration, composition, amount of 
material involved, quantity, and volume. They may appear as papules, nodules, or 
erythematous plaques which harden over time due to fibrosis. The time gap between 
entrance of the foreign body into the skin and appearance of granulomas is very 
variable, sometimes being as long as several years.
Among the endogenous substances, hair, calcifications, cholesterol crystals, or 
uric acid are common; while exogenous substances commonly include insects, silica 
(talc), beryllium, aluminum, or tattoo ink.
In recent years, the use of cosmetic materials and, in some cases, the 
implantation of medical material have been implicated in this regard. In recent 
years, a granulomatous and inflammatory systemic picture secondary to a foreign 
body reaction has been defined by diverse substances such as biomaterial injections 
and prostheses (mainly silicone, hyaluronic acid, acrylamides, and methacrylate 
compounds). The process is defined as autoimmune/inflammatory syndrome 
induced by adjuvants (ASIA) and is characterized by chronic fatigue, pyrexia, dry 
mouth, sleep disturbances, myalgia, myositis, muscle weakness, lymph nodes, 
arthralgia and/or arthritis, and foreign body-type granuloma, in the absence of any 
autoantibody, infection, or cancer. Symptoms may disappear after removal of the 
implant material [3].
2.3 Localized infectious granulomas
Infectious granulomas are usually chronic and localized skin infections, the 
agent being mycobacteria (tuberculosis or atypical mycobacteria), parasites 
(leishmaniasis), or fungi (cryptococcosis) in an immunocompromised host. With 
the exception of cutaneous leishmaniasis, granulomatous infections have to be 
considered as skin manifestations of systemic infections. They thus require systemic 
treatment directed toward the cause.
2.3.1 Cutaneous tuberculosis (TB)
Cutaneous tuberculosis (TB) accounts for less than 2% of all extrapulmonary 
tuberculosis manifestations and occurs in 10% of all patients with TB.  
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Skin manifestations of TB represent a clinical polymorphism that can be 
explained by various factors such as the pathogenicity of the bacterial strain, 
the immune status of the host, previous treatment, or local factors (i.e., prox-
imity to lymph nodes). Localized forms include lupus vulgaris, a violaceous 
yellowish cutaneous plaque with serpiginous centrifugal extension, desquama-
tion, and central atrophy, scrofuloderma (an erythemato-violaceous painless 
nodule, with suppuration as sign of per contiguitatem extension of ganglionic, 
osteoarticular), or epididymal tuberculosis or verrucous cutaneous tuberculosis 
(a keratotic plaque with irregular edges and dystrophic scarring on the skin of 
the hands). Cutaneous atypical mycobacteria infections have heterogeneous 
clinical appearance, including nodules, papules, plaques, pustules, abscess, 
and ulcers. Mycobacterium marinum is the most commonly involved strain. It 
causes skin and soft tissue infections after exposure to aquatic environments 
or marine animals (“tank granuloma”). Patients typically show clusters of 
nodules, ulcers, or verrucous plaques that may spread from the arms or legs in a 
sporotrichoid pattern. Mycobacterium chelonae is a rapidly growing mycobac-
terium that causes dark red nodules and, occasionally, abscesses. The infection 
is related to skin wounds due to penetration procedures (injection, liposuction, 
 acupuncture, tattoos, etc.).
2.3.2 Cutaneous lesihmaniasis
Cutaneous leishmaniasis involves exposed body parts, causing nodules, ulcers, 
and scarring. Acute cutaneous leishmaniasis or East button is the most common 
form. The lesion, initially papular, rounded or oval, and asymptomatic or mildly 
pruritic, may be single or multiple and commonly located on the face or areas of 
uncovered skin. Gradually it takes a darker reddish tone while it infiltrates and 
increases in size. The surface is occasionally covered with furfuraceous scales 
and, in 1–3 months, is transformed into a nodular lesion or a deep infiltrated 
plaque. Chronic cutaneous leishmaniasis includes cases that exceed the duration of 
1–2 years. The lesions are usually more polymorphic (large indurated plaques with 
papular borders, eczematiform, warty, keloidal, etc.), and the clinical difficulty of 
the diagnosis is due to the lower sensitivity of microscopic smear examination, the 
crops, and the histopathology.
2.4 Syndromic mucocutaneous granulomatous disorders
Cutaneous nonnecrotizing/necrobiotic granulomas may be part of syndromic 
complexes that include lesions in other organs and tissues as well. The two 
principal representatives of this group are the Melkersson-Rosenthal syndrome 
(orofacial mucocutaneous granulomatosis; cheilitis granulomatosa) and Blau 
syndrome [2].
The constituent signs of Melkersson-Rosenthal syndrome include the associa-
tion of recurrent facial and/or lip edema, recurrent facial paralysis, and fissured 
tongue. It has been associated with Crohn’s disease. Miescher’s cheilitis granuloma-
tous consists of the appearance of recurrent labial edema in one or both lips, which 
can be persistent. It has traditionally been considered as a monosymptomatic form 
of Melkersson-Rosenthal syndrome.
Blau syndrome is an autosomal-dominant autoinflammatory condition that 
includes granulomatous inflammation in the skin, together with granulomatous 
iridocyclitis and granulomatous arthritis with camptodactyly. It is related to 
mutations in the CARD15/NOD2 gene complex and may also have a linkage to 
Crohn’s disease.
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3. Systemic granulomatosis diseases
3.1 Infectious disseminated granuloma
Almost all infectious pathogens can induce granulomas (Table 1). Although the 
skin tends to be frequently affected, visceral involvement is usually coexisting, as is 
a systemic inflammatory process (fever, asthenia, etc.). There is no universal pat-
tern of visceral or cutaneous involvement; the epidemiological and clinical context 
is essential, and physical history can provide data on the etiological agent.
Among infectious agents, mycobacteria are the most frequently involved. In 
tuberculosis and leprosy, there is either a true skin infection or tuberculids, which are 
regarded as a cutaneous hypersensitivity reaction to Mycobacterium leprae linked to 
the release of an antigen by an internal mycobacteria infectious focus. Skin tuberculid 
lesions are not contagious. The clinical manifestations of tuberculosis tuberculids 
are erythema nodosum, erythema induratum of Bazin, papulonecrotic tuberculids, 
lichen scrofulosorum, and lupus miliaris disseminatus faciei, whose differential diag-
nosis is granulomatous rosacea. Some agents have tropism due to specific viscera, such 
as bartonella due to the liver or the vascular affectation of syphilis. Some viruses are 
associated with specific vasculitic systemic processes, such as panarteritis nodosa in 
the case of hepatitis B or vasculitis cryoglobulinemia induced by the hepatitis C virus.
3.2 Noninfectious disseminated granuloma
There are many etiologies of noninfectious disseminated granulomas (Table 2). 
Possibly sarcoidosis is the prototype of these diseases, although it will not be 
Bacteria Virus Fungi Parasites
M. tuberculosis
M. marinum
M. chelonae
M. avium (MAI)
M. leprae
T. pallidum 
(syphilis)
Salmonella sp.
Bartonella 
henselae
Kleb. 
granulomatis
(donovanosis)
Listeriosis
Brucella
Pasteurella
Yersinia
Nocardia
T. whipplei
Rhodococcus equi
Tularemia
Melioidosis
Coxiella burnetii
Borrelia 
burgdorferi
Human 
immunodeficiency 
virus
Epstein-Barr virus
Cytomegalovirus
Hepatitis B virus
Hepatitis C virus
Candida sp.
Aspergillus sp.
Cryptococcosis
Histoplasmosis
Blastomycosis
Coccidioidomycosis
Paracoccidioidomycosis
Penicillium
Sporothrix schenckii
Pneumocystis jiroveci
Toxoplasmosis
Leishmania sp.
Bilharzia
Toxocara canis
Capillaria hepatica
Ascaris
Strongyloides
Giardia lamblia
Fasciola
Schistosomiasis
Enterobius 
vermicularis 
(pinworms)
Echinococcus 
granulosus
Echinococcus 
multilocularis
Table 1. 
Common infectious diseases causing disseminated granulomatosis.
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Immune-mediated inflammatory diseases
A. Organ specifies primarily
• Sarcoidosis
• Bronchogenic granulomatosis
• Inflammatory bowel disease
• Autoimmune hepatitis
• Primary biliary cirrhosis
• Primary sclerosing cholangitis
• Idiopathic eosinophilic gastroenteritis
• Chronic idiopathic inflammatory bowel disease
B. Systemic
• Lupus erythematosus
• Rheumatoid arthritis
• Polyarteritis nodosa
• Granulomatosis with polyangiitis (Wegener)
• Eosinophilic granulomatosis with polyangiitis (Churg-Strauss)
Neoplasia/clonal diseases
C. Hematological
• Lymphoma
 ◯ Cutaneous: mycosis fungoides T-cell lymphoma (granulomatous)
 ◯ Systemic:
 ◯ Hodgkin
 ◯ Non-Hodgkin
• Myelodysplastic syndrome
D. Solid tumors
• Primary: lung, breast, uterus, prostate, hepatocellular carcinoma
• Granulomatous reaction to metastases
Metabolic
E. Diabetes mellitus
F. Dyslipidemia
G. Thyroid disease
Toxic
H. Drugs: antihypertensives (angiotensin-converting enzyme inhibitors, calcium channel blockers, beta 
blockers, diuretics, hydralazine), hypolipidemic agents, anticonvulsants (phenytoin, topiramate), 
quinidine, antihistaminics, allopurinol, antimicrobials (nitrofurantoin, isoniazid), and others (beryllium, 
gold, copper toxicity, talc).
I. Immunotherapy and growth factors: interferon α, G-CSF, anti-TNF-α, IFN-α
Immunodeficiency
J. Common variable immunodeficiency
K. Wiskott-Aldrich syndrome
L. Chronic granulomatous diseases
Idiopathic
Table 2. 
Causes of noninfectious systemic granulomas.
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addressed in this chapter. Not all immune-mediated systemic processes should 
be assimilated as diseases capable of producing granulomas. For example, in the 
disease related to IgG4, although cases of pulmonary lymphomatoid granulo-
matosis associated with it have been described, two findings are extraordinary 
and practically discard it, namely, the presence of granulomas and the presence 
of a neutrophilic infiltrate [4, 5]. In this same sense we must refer to the diseases 
included in the so-called xanthogranulomatous diseases (Langerhans cell histiocy-
tosis, Erdheim-Chester disease, Rosai-Dorfman disease, hemophagocytic lympho-
histiocytosis, and juvenile xanthogranuloma) where space-occupying lesions can 
be seen in imaging techniques and a histiocytic infiltrate in biopsies, but rarely 
granulomas [6].
3.2.1 Chronic gastrointestinal and chronic biliary diseases
Granulomas have been reported in a small minority of patients with ulcerative 
colitis, Crohn’s disease, and idiopathic eosinophilic gastroenteritis. It is unclear 
whether the granulomas associated with chronic idiopathic inflammatory bowel 
disease could be due to diseases such as primary sclerosing cholangitis or an adverse 
drug reaction. Granulomas may also be a feature of idiopathic eosinophilic enteritis 
involving the hepatobiliary tree by the disease.
Granulomas are reported very frequently (more than 50% in many series) 
in primary biliary cirrhosis cases. They may be portal or lobular, but are often 
associated with duct lesions. However, granulomas are also seen in a minority of 
cases in primary sclerosing cholangitis, in which they are usually well formed and 
non-necrotizing.
3.2.2 Vasculitis and collagen vascular diseases
Granulomas may involve the vasculature in collagen vascular diseases, like 
lupus erythematosus systemic, or more usually in vasculitic diseases including 
systemic necrotizing vasculitis and giant cell arteritis. Systemic necrotizing 
vasculitis is a group of heterogeneous diseases characterized clinically by a greater 
presentation and histologically by the presence of fibrinoid necrosis more intense 
than that seen in in other forms of vasculitis. Panarteritis nodosa is a vasculitis 
that characteristically affects the arteries of medium and small sizes. Vasculitis 
associated with antineutrophil cytoplasmic antibodies include granulomatosis 
accompanied by polyangiitis, microscopic polyarteritis, and granulomatous 
allergic angiitis.
3.2.3 Adverse drug reaction
After the skin, the liver is a frequent focus of granulomas secondary to drugs. 
Granulomas associated with adverse drug reactions may be well or poorly formed, 
but necrosis is very rare. Giant cells may be present, and there is a variable 
associated inflammatory infiltrate that may include lymphocytes, plasma cells, and 
eosinophils. There may be associated duct and/or vascular injury. The combination 
of granulomatous inflammation with significant hepatocellular injury strongly 
suggests drug-associated liver injury [7].
3.2.4 Primary immunodeficiency
As in severely immunosuppressed patients (transplant patients, 
advanced HIV, etc.), cases of primary immunodeficiencies and systemic 
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granulomatous complications, either primary or following opportunistic 
 infections, may appear.
Common variable immunodeficiency comprises a heterogeneous group of 
diseases characterized by a significant hypogammaglobulinemia of unknown cause, 
failure to produce specific antibodies after immunization, and susceptibility to 
bacterial infections, but others develop complications, like granulomas or autoim-
mune diseases. Sarcoid-like granulomas are also well described in the liver, spleen, 
and lung in patients with common variable immunodeficiency [8]. This involve-
ment is usually associated with other autoimmune manifestations and has a worse 
prognosis.
Chronic granulomatous disease is a rare primary immunodeficiency caused by 
an inherited defect in the genes encoding any of the NADPH oxidase components 
responsible for the respiratory burst of phagocytic leukocytes. The NADPH 
oxidase is responsible for the production of reactive oxygen species (ROS) in 
the activated phagocyte (“respiratory burst”). When present, mutations on the 
NAPDH oxidase genes do not allow ROS production, making the neutrophils of 
these patients incapable of destroying pathogens. These patients are especially 
susceptible to infections by staphylococcus, fungi and some gram-negative bacteria. 
The main clinical manifestations include recurrent life-threatening episodes of 
lymphadenitis, abscess, pneumonias, osteomyelitis, granuloma formation, and 
sepsis [8].
3.2.5 Interstitial granulomatous dermatitis
It is important to recognize interstitial granulomatous dermatitis, because 
although it can sometimes occur as an isolated skin disease, it is often associated 
with a systemic disease, which marks the prognosis of the patient; thus an active 
study should be carried out [4]. Ackerman first described this rare type of der-
matitis in 1993. Although the original manifestation has been described as sub-
cutaneous linear nodules (also known as rope sign), later reports showed a quite 
heterogeneous clinical spectrum ranging from hyperpigmented, erythematous 
papules, subcutaneous plaques, and annular lesions to firm red purplish nodules. 
The lesions are usually asymptomatic, but can be slightly pruritic or painful. 
The histopathological examination confirms the diagnosis and is characterized 
by a dense and diffuse interstitial infiltrate in the reticular dermis, composed of 
histiocytes in a palisade arrangement, sometimes with necrobiosis of collagen 
and neutrophils and eosinophils. Interstitial granulomatous dermatitis has been 
associated with various systemic diseases, including autoimmune diseases such as 
rheumatoid arthritis (the most common), systemic sclerosis, or lupus erythema-
tosus. Recently, a case has been reported in association with primary biliary chol-
angitis. However, other etiologies have been described in isolated cases including 
malignancy or drugs (angiotensin-converting enzyme inhibitors, calcium channel 
blockers, beta blockers, diuretics, TNF-α blockers, etc.) [1, 4].
4. Diagnostic approach
The diagnostic approach must be structured, and the analytical, microbiological, 
or radiological tests must be adapted to the epidemiological factors of the patient’s 
clinical history, as well as to the results of the physical examination. Obtaining a 
biopsy, both for histological and microbiological studies, is fundamental. In cases of 
uncertain etiology, close monitoring should be carried out, given the association of 
granulomas with potentially serious diseases (Table 3).
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5. Conclusion
• Granulomatous disorders are a heterogeneous group of diseases, including 
infections, systemic inflammations, neoplasia, metabolic disorders, and 
chemicals.
• An adequate clinical approach, together with physical examination and basic 
analysis, can guide the diagnostic process. However, biopsy of the lesion is 
usually fundamental.
• The histological type of granuloma is important in the etiological diagnosis, to 
optimize both treatment and follow-up.
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Medical history
• Comorbidities (autoimmune disease, diabetes, immunosuppression)
• Drugs or foreign body or water exposure
• Travels
• Risk exposures (sexual, parenteral drugs, etc.)
Physical examination: Clinical sign-associated diseases
Biopsy (depending on the affected organ and accessibility)
• Histology
• Microbiology
 ◯ Culture (bacteria, mycobacteria)
 ◯ PCR (mycobacteria, parasites, etc.)
Laboratory testing
• Complete blood count, ESR, CRP, creatinine, calcemia, liver enzymes, LDH, glycemia, cholesterol, 
triglycerides, TSH/T4, serum protein electrophoresis, ANA, rheumatoid factor, angiotensin-converting 
enzyme
• Serology for HIV, syphilis, hepatitis B and C, and others according to clinical suspicion
Mantoux or interferon gamma release assays for TB
Radiological tests
• Chest X-ray and abdomen and pelvic ultrasound
• Others according to clinical suspicion: CT scan, PET-CT, etc.
Table 3. 
Diagnostic approach to granulomatous diseases.
11
Granulomatous Diseases Mimicking Sarcoidosis
DOI: http://dx.doi.org/10.5772/intechopen.92233
Author details
Angel Robles-Marhuenda
Unidad de Enfermedades Autoinmunes Sistémicas, Servicio de Medicina Interna, 
Hospital Universitario La Paz, Madrid, Spain
*Address all correspondence to: aroblesmarhuenda@gmail.com
© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
12
Sarcoidosis and Granulomatosis - Diagnosis and Management
[1] Terziroli B, Mainetti C, Peeters MA, 
Laffitte E. Cutaneous granulomatosis: 
A comprehensive review. Clinical 
Reviews in Allergy and Immunology. 
2018;54:131-146. DOI: 10.1007/
s12016-017-8666-8
[2] Wick MR. Granulomatous & 
histiocytic dermatitides. Seminars in 
Diagnostic Pathology. 2017;34:301-311. 
DOI: 10.1053/j.semdp.2016.12.003
[3] Alijotas-Reig J, Esteve-Valverde E, 
Gil-Aliberas N, Garcia-Gimenez V. 
Autoimmune/inflammatory syndrome 
induced by adjuvants—ASIA—related 
to biomaterials: Analysis of 45 cases and 
comprehensive review of the literature. 
Immunologic Research. 2017;66:120-
140. DOI: 10.1007/s12026-017-8980-5
[4] Deshpande V, Zen Y, Chan JK, Yi EE, 
Sato Y, Yoshino T, et al. Consensus 
statement on the pathology of IgG4-
related disease. Modern Pathology. 
2012;25:1181-1192. DOI: 10.1038/
modpathol.2012.72
[5] Lamps LW. Hepatic granulomas: 
A review with emphasis on infectious 
causes. Archives of Pathology & 
Laboratory Medicine. 2015;139:867-875. 
DOI: 10.5858/arpa.2014-0123-RA
[6] Bourm KS, Menias CO, Ali K, 
Alhalabi K, Elsayes KM. Spectrum of 
xanthogranulomatous processes in 
the abdomen and pelvis: A pictorial 
review of infectious, inflammatory, and 
proliferative responses. AJR. American 
Journal of Roentgenology. 2017;208: 
475-484. DOI: 10.2214/AJR.16.17075
[7] Dodiuk-Gad RP, Shear NH. 
Granulomatous drug eruptions. 
Dermatologic Clinics. 2015;33:525-539. 
DOI: 10.1016/j.det.2015.03.015
[8] Picard C, Al-Herz W, Bousfiha A, 
Casanova J-L, Chatila T, Conley ME, 
et al. Primary immunodeficiency 
diseases: An update on the 
classification from the International 
Union of Immunological Societies 
Expert Committee for Primary 
Immunodeficiency 2015. Journal of 
Clinical Immunology. 2015;35:696-726. 
DOI: 10.1007/s10875-015-0201-1
References
